Доступ предоставлен для: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems
Главный редактор: Mandip Sachdeva Singh (open in a new tab)

Выходит 6 номеров в год

ISSN Печать: 0743-4863

ISSN Онлайн: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Antibodies and Peptides in Cancer Therapy

Том 23, Выпуск 5, 2006, pp. 401-436
DOI: 10.1615/CritRevTherDrugCarrierSyst.v23.i5.20
Get accessGet access

Краткое описание

Antibodies and peptides play a variety of roles in cancer therapy: monoclonal antibodies (mAbs) and peptides are directly used in anticancer therapy and also as targeting moieties. More than 10 mAbs, either unconjugated or in immunoconjugate forms have been approved for use in oncology. Various peptides, tumor necrosis factors (TNFs), and cell surface-targeted peptides have been identified using phage-display libraries. In combination with standard chemotherapeutic agents, mAbs and peptides can significantly increase the toxicity of anticancer drugs to tumors and reduce their adverse side effects on normal tissues. The present review summarizes some major applications of antibodies and peptides in cancer therapy.

ЦИТИРОВАНО В
  1. Shamay Yosi, Shpirt Lina, Ashkenasy Gonen, David Ayelet, Complexation of Cell-Penetrating Peptide–Polymer Conjugates with Polyanions Controls Cells Uptake of HPMA Copolymers and Anti-tumor Activity, Pharmaceutical Research, 31, 3, 2014. Crossref

  2. Nakazawa Hikaru, Ikeuchi Akinori, Kim Do-Myoung, Ishigaki Yuri, Asano Hidetaka, Kouda Katsunori, Kumagai Izumi, Umetsu Mitsuo, Biomass-binding peptides designed by molecular evolution for efficient degradation of cellulose in biomass by cellulase, Green Chemistry, 15, 2, 2013. Crossref

  3. Kratz Felix, Müller Ivonne A., Ryppa Claudia, Warnecke André, Prodrug Strategies in Anticancer Chemotherapy, ChemMedChem, 3, 1, 2008. Crossref

  4. Tomiyama Tetsuro, Kang Jeong-Hun, Toita Riki, Niidome Takuro, Katayama Yoshiki, Protein kinase Cα-responsive polymeric carrier: its application for gene delivery into human cancers, Cancer Science, 100, 8, 2009. Crossref

  5. Juliano Rudolph L, Alam Rowshon, Dixit Vidula, Kang Hyun Min, Cell‐targeting and cell‐penetrating peptides for delivery of therapeutic and imaging agents, WIREs Nanomedicine and Nanobiotechnology, 1, 3, 2009. Crossref

  6. Kang Jeong-Hun, Toita Riki, Murata Masaharu, Liver cell-targeted delivery of therapeutic molecules, Critical Reviews in Biotechnology, 36, 1, 2016. Crossref

  7. DiVittorio Kristy M., Leevy W. Matthew, O'Neil Edward J., Johnson James R., Vakulenko Sergei, Morris Joshua D., Rosek Kristine D., Serazin Nathan, Hilkert Sarah, Hurley Scott, Marquez Manuel, Smith Bradley D., Zinc(II) Coordination Complexes as Membrane-Active Fluorescent Probes and Antibiotics, ChemBioChem, 9, 2, 2008. Crossref

  8. Palivan Cornelia G., Fischer-Onaca Ozana, Delcea Mihaela, Itel Fabian, Meier Wolfgang, Protein–polymer nanoreactors for medical applications, Chem. Soc. Rev., 41, 7, 2012. Crossref

  9. Potala Sirisha, Sahoo Sanjeeb K., Verma Rama S., Targeted therapy of cancer using diphtheria toxin-derived immunotoxins, Drug Discovery Today, 13, 17-18, 2008. Crossref

  10. Fitting Jenny, Blume Tobias, ten Haaf Andre, Blau Wolfgang, Gattenlöhner Stefan, Tur Mehmet Kemal, Barth Stefan, Phage display-based generation of novel internalizing antibody fragments for immunotoxin-based treatment of acute myeloid leukemia, mAbs, 7, 2, 2015. Crossref

  11. Kim Mee Young, Kim Ok Ran, Choi Yong Seok, Lee Heuiran, Park Keerang, Lee Choon-Taek, Kang Keon Wook, Jeong Sunjoo, Selection and characterization of tenascin C targeting peptide, Molecules and Cells, 33, 1, 2012. Crossref

  12. Kuzmov Andriy, Minko Tamara, Nanotechnology approaches for inhalation treatment of lung diseases, Journal of Controlled Release, 219, 2015. Crossref

  13. Huan Meng-lei, Zhou Si-yuan, Teng Zeng-hui, Zhang Bang-le, Liu Xin-you, Wang Jie-pin, Mei Qi-bing, Conjugation with α-linolenic acid improves cancer cell uptake and cytotoxicity of doxorubicin, Bioorganic & Medicinal Chemistry Letters, 19, 9, 2009. Crossref

  14. Balasubramanian V, Onaca Ozana, Enea Ramona, Hughes David W, Palivan Cornelia G, Protein delivery: from conventional drug delivery carriers to polymeric nanoreactors, Expert Opinion on Drug Delivery, 7, 1, 2010. Crossref

  15. Site-Specific Drug Delivery Utilizing Monoclonal Antibodies, in Drug Delivery Systems, Third Edition, 2011. Crossref

  16. Kapoor Pallavi, Singh Harinder, Gautam Ankur, Chaudhary Kumardeep, Kumar Rahul, Raghava Gajendra P. S., Xue Bin, TumorHoPe: A Database of Tumor Homing Peptides, PLoS ONE, 7, 4, 2012. Crossref

  17. Ljubimova Julia Y., Black Keith L., Ljubimov Alexander V., Holler Eggehard, Biodegradable Multitargeting Nanoconjugates for Drug Delivery, in Multifunctional Pharmaceutical Nanocarriers, 4, 2008. Crossref

  18. Muinao Thingreila, Deka Boruah Hari Prasanna, Pal Mintu, Current advances on polysaccharide-based nanoconjugates for efficient and targeted drug delivery in cancer treatment, in Polysaccharide Carriers for Drug Delivery, 2019. Crossref

  19. BÖHMOVÁ E., POLA R., Peptide-Targeted Polymer Cancerostatics, Physiological Research, 2016. Crossref

  20. Rajavenkatesh Krishnamoorthy, Padmaja Murali, Janani Indrakumar, Aishwarya Satish, Purna Sai Korrapati, Thennarasu Sathiah, Design and synthesis of a novel peptide for selective detection of cancer cells, Chemical Biology & Drug Design, 95, 6, 2020. Crossref

  21. Majumder Joydeb, Minko Tamara, Targeted Nanotherapeutics for Respiratory Diseases: Cancer, Fibrosis, and Coronavirus, Advanced Therapeutics, 4, 2, 2021. Crossref

  22. Ljubimova Julia Y, Fujita Manabu, Ljubimov Alexander V, Torchilin Vladimir P, Black Keith L, Holler Eggehard, Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery, Nanomedicine, 3, 2, 2008. Crossref

  23. Wang Tao, Kulkarni Nikita, D’Souza Gerard G. M., Petrenko Valery A., Torchilin Vladimir P., On the Mechanism of Targeting of Phage Fusion Protein-Modified Nanocarriers: Only the Binding Peptide Sequence Matters, Molecular Pharmaceutics, 8, 5, 2011. Crossref

  24. Liang Chun-hui, Ye Wei-liang, Zhu Chun-lai, Na Ren, Cheng Ying, Cui Han, Liu Dao-zhou, Yang Zhi-fu, Zhou Si-yuan, Synthesis of Doxorubicin α-Linolenic Acid Conjugate and Evaluation of Its Antitumor Activity, Molecular Pharmaceutics, 11, 5, 2014. Crossref

  25. Schwartz Rowena, Goolsby Tiffany V., Messersmith Wells A., Principles of Chemotherapy, in Interventional Oncology, 2008. Crossref

  26. Kang Jeong-Hun, Toita Riki, Katayama Yoshiki, Bio and nanotechnological strategies for tumor-targeted gene therapy, Biotechnology Advances, 28, 6, 2010. Crossref

  27. Thakur Reena , Suri Chander Raman , Kaur Indu Pal, Rishi Praveen, Peptides as Diagnostic, Therapeutic, and Theranostic Tools: Progress and Future Challenges , Critical Reviews™ in Therapeutic Drug Carrier Systems, 40, 1, 2023. Crossref

Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции Цены и условия подписки Begell House Контакты Language English 中文 Русский Português German French Spain